Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

A timely warning: Clock drawing errors in young adults and the long-term validity of cognitive screens.

The Clinical neuropsychologist·2026
Same author

Liver Conditions Specific to Pregnancy: Optimizing Management and Outcomes.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology·2026
Same author

EASL position paper on palliative care in advanced chronic liver disease.

JHEP reports : innovation in hepatology·2026
Same author

Regulatory T-cells in autoimmune hepatitis: An historical perspective with hints to the future.

JHEP reports : innovation in hepatology·2026
Same author

The ethics of unlicensed therapy use in primary biliary cholangitis: a counter view.

Nature reviews. Gastroenterology & hepatology·2026
Same author

Neural responses to acute hypoxia and hyperoxia.

Neuroscience·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: May 10, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

La hepatitis autoinmune es una enfermedad autoinmune.

Michael A Heneghan1, Andrew D Yeoman, Sumita Verma

  • 1Institute of Liver Studies, King's College Hospital NHS Foundation Trust, Denmark Hill, London, UK.

Lancet (London, England)
|June 18, 2013
PubMed
Resumen
Este resumen es generado por máquina.

La hepatitis autoinmune, una enfermedad hepática mediada por el sistema inmunológico, se puede tratar con eficacia en la mayoría de los casos. Las terapias avanzadas como el trasplante de hígado ofrecen soluciones para la enfermedad hepática grave o terminal.

Más Videos Relacionados

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Videos de Experimentos Relacionados

Last Updated: May 10, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Área de la Ciencia:

  • Hepatología Hepatología.
  • Inmunología Inmunología.
  • Medicina interna es la medicina interna de las enfermedades.

Sus antecedentes:

  • La hepatitis autoinmune (HAI) es una enfermedad del parénquima hepático con presentaciones agudas y crónicas.
  • AIH comparte características con otras enfermedades autoinmunes, incluidos anticuerpos no específicos de órganos y autoinmunidad hepática, lo que complica su fisiopatología.
  • Investigaciones recientes destacan el papel de las células T reguladoras en la patogénesis de la AIH.

Objetivo del estudio:

  • Para resumir la comprensión actual de la hepatitis autoinmune.
  • Para discutir los desafíos de diagnóstico y las estrategias terapéuticas.
  • Para resaltar la importancia de considerar los síndromes variantes.

Principales métodos:

  • Revisión de la literatura científica reciente sobre la hepatitis autoinmune.
  • Análisis de los datos relativos a los desencadenantes de enfermedades y la susceptibilidad genética.
  • Evaluación de los resultados del tratamiento y la eficacia del trasplante.

Principales resultados:

  • Hasta el 85% de los pacientes logran remisión clínica y bioquímica con los tratamientos actuales.
  • Hay estrategias alternativas de inmunosupresión disponibles para las personas que no responden.
  • El trasplante de hígado es altamente efectivo para la insuficiencia hepática aguda y las complicaciones de la enfermedad en etapa terminal como el carcinoma hepatocelular.

Conclusiones:

  • La hepatitis autoinmune es una condición manejable con altas tasas de remisión.
  • La susceptibilidad genética y los desencadenantes ambientales juegan un papel en el desarrollo de la enfermedad.
  • El trasplante de hígado sigue siendo una opción crítica para las etapas avanzadas de la enfermedad.